HCID 53739287, compound → HCID 54124626, compound
Reaction equation
C1(=O)[N:5]([CH2:6][C:7]2[N:11]=[C:10]([C:12]3[N:13]=[CH:14][N:15]4[C:21]5[CH:22]=[CH:23][CH:24]=[CH:25][C:20]=5[C:19](=[O:26])[N:18]5[CH2:27][CH2:28][C@H:17]5[C:16]=34)[O:9][N:8]=2)C(=O)C2=CC=CC=C12>C(O)C.CN>[NH2:5][CH2:6][C:7]1[N:11]=[C:10]([C:12]2[N:13]=[CH:14][N:15]3[C:21]4[CH:22]=[CH:23][CH:24]=[CH:25][C:20]=4[C:19](=[O:26])[N:18]4[CH2:27][CH2:28][C@H:17]4[C:16]=23)[O:9][N:8]=1Participants
4
Reactant 1
Product 1
Reagents, catalysts & solvents 2
Procedure
9 g (19.9 mmol) of (S)-12,12a-dihydro-1-(3-phthalimidomethyl-1,2,4-oxadiazol-5-yl)-9H,11H-azeto[2,1-c]imidazo[1,5-a][1,4]benzodiazepin-9-one in 20 ml of ethanol and 65 ml of methylamine (33%) in ethanol were stirred at 70° for 2 hours. The solution was concentrated and the residue was triturated with 70 ml of methylene chloride. The suspension obtained was filtered. After drying the filter residue there was obtained (S)-1-(3-aminomethyl-1,2,4-oxadiazol-5-yl)-12,12a-dihydro-9H,11H-azeto[2,1-c]imidazo[1,5-a][1,4]benzodiazepin-9-one, which was used without further crystallization as the starting material for the Example described hereinafter.
Workup
- concentrationThe solution was concentrated
- customthe residue was triturated with 70 ml of methylene chloride
- customThe suspension obtained
- filtrationwas filtered
- customAfter drying the filter residue
Sources & evidence
- ORD record
- ord-0969d485cf7f498989746bebd14f80b9
- Source dataset
- uspto-grants-1997_09
- Patent number
- US05665718
Reaction notes
Loading…